Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company,…
331,297$
0,02%
Echtzeit-Aktienkurs Alnylam Pharmaceuticals Inc.
Bid:
Ask: